EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway

Zhongfu Tang, Lili Cheng iD, Ming Li iD, Chuanbing Huang

Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-19

DOI: 10.2147/dddt.s607142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Zhongfu Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, People's Republic of China. Hauptthemen laut MEDLINE: Lupus Nephritis, Triterpenes, Saponins, Ferroptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisTriterpenesSaponinsFerroptosisPodocytesAnimalsProto-Oncogene Proteins c-aktMiceNF-E2-Related Factor 2Phosphatidylinositol 3-KinasesFemaleMice, Inbred MRL lprSignal TransductionCells, CulturedDisease Models, AnimalMolecular Docking SimulationDose-Response Relationship, DrugStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

Astragaloside IVferroptosislupus nephritispodocytesrenal damage

Substanzen

astragaloside ATriterpenesSaponinsProto-Oncogene Proteins c-aktNF-E2-Related Factor 2Phosphatidylinositol 3-KinasesNfe2l2 protein, mouse

Autor:innen und Institutionen

  • Department of Rheumatology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, People's Republic of China.
  • Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, People's Republic of China.

ORCID-Profile: Lili Cheng, Ming Li

Zitieren

APA

Tang, Z., Cheng, L., Li, M., & Huang, C. (2026). Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway. Drug Design, Development and Therapy, Volume 20, 1-19. https://doi.org/10.2147/dddt.s607142

Vancouver

Tang Z, Cheng L, Li M, Huang C. Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway. Drug Design, Development and Therapy. 2026;Volume 20:1-19. doi:10.2147/dddt.s607142

BibTeX
@article{Tang2026,
  author = {Tang, Zhongfu and Cheng, Lili and Li, Ming and Huang, Chuanbing},
  title = {Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--19},
  doi = {10.2147/dddt.s607142}
}
Kostenlos starten →